Table 2.
LETM initial treatment
| This cohort | |
|---|---|
| Delay of treatment after first symptoms (mean, days) | 10 |
| First line of treatment (n = 53/53) | |
| Infusions of methylprednisolone | 52 (98%) |
| Second line of treatment (n = 24/53) | |
| Plasmapheresis | 17 (71%) |
| Infusions of methylprednisolone | 5 (21%) |
| IV immunoglobulins | 2 (8%) |
| Third line of treatment (n = 4/53) | |
| Infusions of methylprednisolone | 2 (50%) |
| Plasmapheresis | 2 (50%) |
| Relay by oral steroids (n = 23/53) | |
| Duration (data for 15 patients) months | 7.2 (0.2–12) |
LETM longitudinal extensive transverse myelitis, IV intravenous